Myasthenia gravis secondary prevention

Myasthenia gravis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myasthenia Gravis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myasthenia gravis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myasthenia gravis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myasthenia gravis secondary prevention
CDC on Myasthenia gravis secondary prevention
Myasthenia gravis secondary prevention in the news
Blogs on Myasthenia gravis secondary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Myasthenia gravis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are no established measures for the secondary prevention of Myasthenia gravis.

Secondary Prevention

There are no established measures for the secondary prevention of Myasthenia gravis.

References

Template:WH Template:WS